BlossomHill Therapeutics, Inc. BLSM
12.38 USD -0.03 (-0.24%)
At closeNov 4, 2026, 4:00 PM EST
12.38 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
11.24 Day range 13.00
11.24 52-week range 27.99
- YTD
- -22.62%
- 1 year
- -22.62%
Financial health
FMP rating
C2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 2
Valuation
P/E -7.7×
FY 2024 5y median -11.4× FY 2025
P/S 0.0×
FY 2024 5y median 0.0× FY 2025
P/B -3.5×
FY 2024 5y median -5.0× FY 2025
P/FCF -9.7×
FY 2024 5y median -12.2× FY 2025
EV/EBITDA -5.5×
FY 2024 5y median -7.8× FY 2025
EV/Sales 0.0×
FY 2024 5y median 0.0× FY 2025
FCF Yield -10.3%
FY 2024 5y median -8.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2024 5y median 0.0% FY 2025
ROE 46.0%
FY 2024 5y median 44.0% FY 2025
ROIC -43.4%
FY 2024 5y median -39.8% FY 2025
ROA -37.2%
FY 2024 5y median -33.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income -75.9%
FY 2024 FY 2025
EPS (diluted) -96.2%
FY 2024 FY 2025
Free Cash Flow -52.3%
FY 2024 FY 2025
Financial Health
Current Ratio 9.0×
FY 2024 5y median 12.2× FY 2025
Quick Ratio 9.0×
FY 2024 5y median 12.2× FY 2025
Debt / Equity -0.2×
FY 2024 5y median -0.1× FY 2025
Net Debt / EBITDA 1.8×
FY 2024 5y median 2.3× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31